The Rice Diet of Central Florida
|
|
|
- Dorcas Higgins
- 5 years ago
- Views:
Transcription
1 The Rice Diet of Central Florida
2 E. H. B/P SYSTOLIC E.H D/C BENICAR/HCT /4/09 8/25/09 9/22/09 10/20/09 11/17/09 12/15/09 BEGAN R/D ON 8/4/09 58 year old male with hypertension on Benicar/HCT began Rice Diet of Central Florida program on 8/4/09 and was able to discontinue his medication by 9/10/09. With continuation of the Rice Diet, his BP continued to fall, despite being off medications due to sodium restriction.
3 B/P Diastolic D/C BENICAR/HCT /4/09 8/25/09 9/22/09 10/20/09 11/17/09 12/15/09 58 year old male with hypertension on Benicar/HCT began Rice Diet of Central Florida program on 8/4/09 and was able to discontinue his medication by 9/10/09. With continuation of the Rice Diet, his BP continued to fall, despite being off medications due to sodium restriction.
4 Blood Sugar(Glucose) D/C METFORMIN 20 8/5/09 8/12/09 8/27/09 9/16/09 9/30/09 12/15/09 1/15/10 2/10/10 58 year old male, diabetic, on oral hypoglycemic medication showed dramatic reduction in fasting blood sugars after beginning the Rice Diet of Central Florida program, and was able to discontinue his Metformin within 2 months and maintain normal fasting blood sugars.
5 W. W. B/P SYSTOLIC /29/09 11/10/09 11/24/09 12/8/09 66 year old male with newly-detected hypertension, was treated only with Rice Diet of Central Florida program and showed dramatic reduction of BP to low normal limits within 6 weeks.
6 B/P DIASTOLIC /29/09 11/10/09 11/24/09 12/8/09 66 year old male with newly-detected hypertension, was treated only with Rice Diet of Central Florida program and showed dramatic reduction of BP to low normal limits within 6 weeks.
7 R. F. BLOOD SUGAR ( GLUCOSE) HbA1c = 6.8 HbA1C=6.8 HbA1C=5.9 11/05/09 11/09/09 11/17/09 11/30/09 1/11/10 3/1/10 61 year old white male with previously-undetected Diabetes was treated only with the Rice Diet of Central Florida program and showed dramatic reduction of fasting blood sugar to the normal range within 1 month and reduction of HbA1C to upper normal limits.
8 B/P SYSTOLIC D/C SPIRONOLACTONE D/C DIOVAN 11/6/09 11/20/09 12/1/09 12/15/09 1/5/10 1/26/10 2/16/10 61 year old male with coronary artery disease and hypertension began treatment with the Rice Diet of Central Florida program and was able to discontinue the 2 anti-hypertensives noted above and continue to maintain normal BP on diet alone over the next 3 months.
9 B/P DIASTOLIC D/C SPIRONOLACTONE D/C DIOVAN 20 11/6/09 11/20/09 12/1/09 12/15/09 1/5/10 1/26/10 2/16/10 61 year old male with coronary artery disease and hypertension began treatment with the Rice Diet of Central Florida program and was able to discontinue the 2 anti-hypertensives noted above and continue to maintain normal BP on diet alone over the next 3 months.
10 W. D. B/P Systolic /19/ /2/ /16/ /30/ /14/ year old female with newly-discovered hypertension was treated with the Rice Diet of Central Florida and was able to attain normal BP within 2 months as demonstrated above.
11 B/P Diastolic /19/09 11/2/09 11/16/09 11/30/09 12/14/09 59 year old female with newly-discovered hypertension was treated with the Rice Diet of Central Florida and was able to attain normal BP within 2 months as demonstrated above.
12 M.B. B/P Systolic D/C ALTACE 11/6/09 12/3/09 1/7/10 2/4/ year old female with hypertension was able to discontinue her medication within 1 month of starting the Rice Diet of Central Florida program and maintain normal BP.
13 B/P Diastolic D//C ALTACE 11/6/09 12/3/09 1/7/10 2/4/10 65 year old female with hypertension was able to discontinue her medication within 1 month of starting the Rice Diet of Central Florida program and maintain normal BP.
14 M.H. B/P Systolic D/C CADUET 11/23/09 12/9/09 12/23/09 1/19/10 67 year old female with hypertension was able to discontinue her anti-hypertensive medication above and continue to maintain BP levels below her levels while on medication by maintaining the Rice Diet of Central Florida program.
15 B/P Diastolic D/C CADUET 11/23/09 12/09/09 12/23/09 1/19/10 67 year old female with hypertension was able to discontinue her anti-hypertensive medication above and continue to maintain BP levels below her levels while on medication by maintaining the Rice Diet of Central Florida program.
16 S.W. B/P SYSTOLIC /13/10 2/9/10 2/23/10 3/2/10 50 year old female with newly-discovered hypertension treated with Rice Diet of Central Florida program. She was able to drop her BP to normal limits within 6 weeks.
17 B/P DIASTOLIC /13/10 2/9/10 2/23/10 3/2/10 50 year old female with newly-discovered hypertension treated with Rice Diet of Central Florida program. She was able to drop her BP to normal limits within 6 weeks.
Patient is healthy with no chronic disease or significant risk factors [16%].
![Patient is healthy with no chronic disease or significant risk factors [16%].](/thumbs/96/129036215.jpg "Patient is healthy with no chronic disease or significant risk factors [16%].")
AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II
Deprivation Study. The Freiburg Study
The Freiburg Study Deprivation Study Free Radicals Inflammation (hs-crp) Blood Pressure (Systolic, Diastolic) Blood Lipids (Cholesterol, Triglycerides) Energy Utilization (Heart Rate) Sugar Metabolism
Diabetes in Renal Patients. Contents. Understanding Diabetic Nephropathy
Diabetes in Renal Patients Contents Understanding Diabetic Nephropathy What effect does CKD have on a patient s diabetic control? Diabetic Drugs in CKD and Dialysis Patients Hyper and Hypoglycaemia in
An Update in Heart Failure
An Update in Heart Failure Dr Peter Dias Cardiologist Heartswest AHFCTS Fiona Stanley Hospital Disclosures No financial, industry, pharma disclosures I am not an endocrinologist References Heart disease
What s New in Bariatric Surgery?
Bariatric Surgery: Update for the General Surgeon What s New in Bariatric Surgery? 2,000 B.C. 2,000 A.D. 1. America keeps getting fatter without an end in sight. 2. Bariatric surgery is not just about
JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
Heart Disease and Prevention PRESENTED BY: DOTTIE CRAIG NP- C, JANE ARCHER NP-C, KATHY DAPPER RN, NICCI FRAVEL RN
Heart Disease and Prevention PRESENTED BY: DOTTIE CRAIG NP- C, JANE ARCHER NP-C, KATHY DAPPER RN, NICCI FRAVEL RN Objectives Identify Normal Systolic and Diastolic Blood pressures Recognize common Antihypertensive
Your health is a crucial aspect of your life. That s why the Yakima Heart Center offers this booklet; to help you identify the numbers that affect
Your health is a crucial aspect of your life. That s why the Yakima Heart Center offers this booklet; to help you identify the numbers that affect your health and well-being. Knowing your medical history
Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital
Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment
Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC
Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007
Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures
Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2
Clinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
Clinical Care Performance. Financial Year 2012 to 2018
Clinical Care Performance Financial Year 2012 to 2018 SHP Clinical Care Performance Diabetes Mellitus Hyperlipidemia Hypertension Diabetes Mellitus Find out how our patients are doing for: HbA1C HbA1c
: Centyr~ 1.25 mg. ~ Centyl 2.5 mg. ~ Renitec(llllO mg. Norvasc 5 mg
CE9401 DK 10 November, 1999 SYNOPSIS Studyc:ode: CE9401 OK Study title: Efficacy and safety of Centyl with potassium chloride (bendroflumethiazide) 1.25 mg and 2.5 mg compared to Renitec (enalapril) 10
A Needs Assessment of Hypertension in Georgia
A Needs Assessment of Hypertension in Georgia Faye Lopez Mercer University School of Medicine Marylen Rimando Mercer University School of Medicine Harshali Khapekar Mercer University School of Medicine
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
Dear Clinicians, We welcome you to us your stories directly at or click "Reply" to this . Thank you!
Dear Clinicians, We have received questions from several clinicians regarding what to do when encountering a patient with a high blood pressure alert or diabetic emergency at a health fair. Attached you
CARE PATHWAYS. Allyson Ashley
CARE PATHWAYS Allyson Ashley WHAT IS A CARE PATHWAY? An explicit statement of the goals and key elements of care based on evidence, best practice, and patient s expectations and their characteristics The
Exercise Considerations for Individuals with Cardiovascular Disease
Exercise Considerations for Individuals with Cardiovascular Disease Mary Woessner, PhD Candidate, MA Victoria University Institute of Health and Sport Cardiovascular Disease Definition: Heart conditions
This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. The synopsis
Diabetes in the Elderly 1, 2, 3
Diabetes in the Elderly 1, 2, 3 WF Mollentze Feb 2010 Diabetes in the elderly differs from diabetes in younger people Prevalence: o Diabetes increases with age affecting approximately 10% of people over
Non-insulin treatment in Type 1 DM Sang Yong Kim
Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay
SCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,
Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant
Cardiovascular System and Health. Chapter 15
Cardiovascular System and Health Chapter 15 Cardiovascular Disease Leading cause of death in U.S. Claims 1 life every 43 seconds Often, the first sign is a fatal heart attack Death Rates #1 CVD #2 Cancer
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
Featured Topic: Low Thyroid (5 slides)
Featured Topic: Low Thyroid (5 slides) Too much, or too little? According to the American Thyroid Association, 60% of women have an undetected thyroid problem at some point in their life Getting the correct
Dr Diana R Holdright. MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION.
Dr Diana R Holdright MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION www.drholdright.co.uk Blood pressure is the pressure exerted on the walls of the arteries when the heart pumps;
Sponsor / Company: Sanofi Drug substance(s): Insulin Glargine (HOE901) Insulin Glulisine (HMR1964)
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):
BLOOD PRESSURE. Unit 3: Transportation and Respiration
BLOOD PRESSURE Unit 3: Transportation and Respiration Blood Pressure The force of your blood pushing on the walls of your arteries. How is Blood Pressure Measured? Measured at an artery in the arm and
High intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes
High intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes Sophie Cassidy, s.cassidy@ncl.ac.uk 1) Concentric remodelling 1.2 * Eccentricity ratio
Galvus the most comprehensively studied DPP-4 inhibitor
Galvus the most comprehensively studied DPP-4 inhibitor! >7 000 patients enrolled in clinical studies! >4 00 patients exposed to Galvus >1 300 patients exposed 2 weeks >300 patients exposed for 104 weeks!
Patient Reported Outcomes: Unpacking Quality Measures Andrew L Brickman, PhD Richard Taaffe, Discussant, CEO WHCHC June 23, 2018
Patient Reported Outcomes: Unpacking Quality Measures Andrew L Brickman, PhD Richard Taaffe, Discussant, CEO WHCHC June 23, 2018 1 Are patient reported outcomes a new thing? Is this the next shiny object?
Cardiovascular Disease Risk Factors:
Cardiovascular Disease Risk Factors: Risk factors are traits or habits that increase a person's chances of having cardiovascular disease. Some risk factors can be changed. These risk factors are high blood
Adherence to Hypertension Visit Protocol Description: % of patients with HTN who are being monitored through follow up visits according to guidelines, based on "days since last BP", which looks back from
Information for people with diabetes. diabetes. glossary of. terms
Information for people with diabetes i diabetes glossary of terms Diabetes is a common condition, which most people have some understanding of, but when you listen to people talk about it, you may feel
Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents
Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances
CONCORD INTERNAL MEDICINE HYPERTENSION PROTOCOL
CONCORD INTERNAL MEDICINE HYPERTENSION PROTOCOL Douglas G. Kelling Jr., MD Carmella Gismondi-Eagan, MD, FACP George C. Monroe, III, MD Revised, April 8, 2012 The information contained in this protocol
Sponsor: Sanofi Drug substance(s): Lantus /insulin glargine. Study Identifiers: U , NCT Study code: LANTUL07225
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor: Sanofi Drug substance(s):
PUBLIC SUMMARY OF RISK MANAGEMENT PLAN (RMP) CANDESARTAN/HYDROCHLOROTHIAZIDE ORION 8 MG/12.5 MG, 16 MG/12.5 MG, 32 MG/12.5 MG, 32 MG/25 MG ORION
PUBLIC SUMMARY OF RISK MANAGEMENT PLAN (RMP) CANDESARTAN/HYDROCHLOROTHIAZIDE ORION 8 MG/12.5 MG, 16 MG/12.5 MG, 32 MG/12.5 MG, 32 MG/25 MG ORION CORPORATION DATE: 17-04-2015, VERSION 2 VI.2 Elements for
SUMMARY OF CHANGES TO QOF 2017/18 - ENGLAND CLINICAL
SUMMARY OF CHANGES TO QOF 2017/18 - ENGLAND KEY No change Retired/replaced Wording and/or timeframe change Point or threshold change Indicator ID change 1/17 QOF ID 17/18 QOF ID NICE ID Indicator wording
Coronary Artery Disease Clinical Practice Guidelines
Coronary Artery Disease Clinical Practice Guidelines Guidelines are systematically developed statements to assist patients and providers in choosing appropriate healthcare for specific clinical conditions.
17/18 Threshold 18/19 Points 18/19. Points NO CHANGE NO CHANGE NO CHANGE
SUMMARY OF CHANGES TO QOF 2018/19 - ENGLAND 18-19 QOF005 KEY No change Retired/replaced Wording and/or timeframe change Point or threshold change Indicator ID change 17/18 QOF ID 18/19 QOF ID NICE ID Indicator
Know Your Numbers. The Life Saving Numbers You Need To Know
Know Your Numbers The Life Saving Numbers You Need To Know Take Charge of Your! You may have heard that you need to Know Your Numbers, which refers to key markers of heart health like blood pressure, waist
Supplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and
HYPERTENSION. Shelby Bublitz Winter Quarter 2015 Cory Ruth NTRS 415A-03 Shelly Truong Professor Owen
HYPERTENSION Shelby Bublitz Winter Quarter 2015 Cory Ruth NTRS 415A-03 Shelly Truong Professor Owen What exactly is HYPERTENSION? Blood pressure is affected either by peripheral resistance or cardiac output.
Managing HTN in the Elderly: How Low to Go
Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular
Tim Church, M.D., M.P.H., Ph.D. John S. McIlhenny Endowed Chair Pennington Biomedical Research Center
Diabetes- What Do You Need to Do Tim Church, M.D., M.P.H., Ph.D. John S. McIlhenny Endowed Chair Pennington Biomedical Research Center 1 Common Myth: You have to run a marathon to benefit from regular
SYNOPSIS. Publications No publications at the time of writing this report.
Drug product: TOPROL-XL Drug substance(s): Metoprolol succinate Study code: D4020C00033 (307A) Date: 8 February 2006 SYNOPSIS Dose Ranging, Safety and Tolerability of TOPROL-XL (metoprolol succinate) Extended-release
Metabolic Syndrome and Chronic Kidney Disease
Metabolic Syndrome and Chronic Kidney Disease Definition of Metabolic Syndrome National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Abdominal obesity, defined as a waist circumference
Φαρµακευτική θεραπεία υπερτασικών ασθενών. Δ. Τσιαχρής, Καρδιολόγος, Α Πανεπιστηµαική Καρδιολογική Κλινική
Φαρµακευτική θεραπεία υπερτασικών ασθενών Δ. Τσιαχρής, Καρδιολόγος, Α Πανεπιστηµαική Καρδιολογική Κλινική A 42-Year-Old Female with True Severe Resistant Hypertension Female, 42 years old, smoker BMI:
Difficult to Treat Hypertension
Difficult to Treat Hypertension According to Goldilocks JNC 8 Blood Pressure Goals (2014) BP Goal 60 years old and greater*- systolic < 150 and diastolic < 90. (Grade A)** BP Goal 18-59 years old* diastolic
Diabetic medications
Diabetic medications Overview May 2018 List of medications ORAL MEDICATIONS o Metformin o Glipizide INJECTABLE MEDICATIONS o o o Tresiba (insulin degludec) Levemir (insulin detemir) NovoLog o NovoLog 70/30
Know Your Numbers. Your guide to maintaining good health. Helpful information from Providence Medical Center and Saint John Hospital
Know Your Numbers Your guide to maintaining good health Helpful information from Providence Medical Center and Saint John Hospital If it has been awhile since your last check up and you are searching for
Metabolic Syndrome.
www.bmiweightloss.com.au What is the metabolic syndrome? The was first described in 1988 by Gerald Reavson It was originally described as the clustering of four conditions These conditions when present
Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
Endocrinology TeleECHO Clinic Case Presentation Form
Endocrinology TeleECHO Clinic Case Presentation Form Complete ALL ITEMS on this form and fax to 503.228.4801 PLEASE NOTE that case consultations do not create or otherwise establish a provider-patient
Group Data Analysis Report
Group Data Analysis Report Generated on 29 July 2016 For Fitech Test Application ( Test June 2016 ) Powered By Fitech - The Fitness Technology Company Page 1 of 18 Introduction The following data analysis
14/15 Threshold 15/16 Points 15/16. Points. Retired Replaced by NM82/AF007. Replacement NO CHANGE
SUMMARY OF CHANGES TO QOF 2015/1 - ENGLAND KEY No change Retired/replaced Wording and/or change Point or threshold change Indicator ID change 14/15 QOF ID 15/1 QOF ID NICE ID Indicator wording Changes
Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to
Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to 90 mmhg. These pressures are called Normal blood pressure
egfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
Clinical Study Synopsis
Clinical Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website or on the website www.clinicalstudyresults.org hosted by the Pharmaceutical Research and
2013 Hypertension Measure Group Patient Visit Form
Please complete the form below for 20 or more unique patients meeting patient sample criteria for the measure group for the current reporting year. A majority (11 or more) patients must be Medicare Part
We know these take time to gather, so please plan ahead!
CDL AND INSULIN CHECKLIST Are you a CDL holder who uses insulin for diabetes? As of November 2018, you can get certified to drive faster, with no waiver application process! Please bring all of the following:
Stroke Awareness. Presented by Jai Cho, MD Director of Stroke Unit Department of Neurology Kaiser Permanente, Santa Clara Medical Center.
Stroke Awareness Presented by Jai Cho, MD Director of Stroke Unit Department of Neurology Kaiser Permanente, Santa Clara Medical Center May 5, 2009 FACTS: Strokes in the U.S. Third leading cause of death
BIOLOGICAL D E T E R M I N AN T S O F H E AL T H ( )
BIOLOGICAL D E T E R M I N AN T S O F H E AL T H ( 3. 1. 5 ) BIOLOGICAL Body weight Blood pressure Birth weight Impaired glucose regulation Genetics Blood Cholesterol BODY WEIGHT The body weight of an
major public health burden
HYPERTENSION INTRODUCTION Hypertension is one of the major public health burden in the recent times. Hypertension remains a challenging medical condition among the noncommunicable diseases of ever growing
!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants
Aggregate Report Fasting Biometric Screening CLIENTXXXX May 2, 2014 21,000 participants Contact:404.636.9437~Website:www.atlantahealthsys.com RISK FACTOR QUESTIONNAIRE Participants Percent Do not exercise
A study on clinical profile of acute coronary syndrome in type 2 diabetes mellitus patients with relevance to HbA1c
Original Research Article A study on clinical profile of acute coronary syndrome in type 2 diabetes mellitus patients with relevance to HbA1c K. Babu Raj 1, G. Sivachandran 2* 1 Reader, 2 Final Year Post
Cardiac Pathophysiology
Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of
Supplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use
Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Baseline characteristics Users (n = 28) Non-users (n = 32) P value Age (years) 67.8 (9.4) 68.4 (8.5)
Risk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
ADVANCE post trial ObservatioNal Study
Hot Topics in Diabetes 50 th EASD, Vienna 2014 ADVANCE post trial ObservatioNal Study Sophia Zoungas The George Institute The University of Sydney Rationale and Study Design Sophia Zoungas The George Institute
Investigators, study sites Multicenter, 35 US sites. Coordinating Investigator: Richard Bergenstal, MD
STUDY SYNOPSIS Study number Title HMR1964A/3502 Apidra (insulin glulisine) administered in a fixed-bolus regimen vs. variable-bolus regimen based on carbohydrate counting in adult subjects with type 2
The Journey towards Total Wellbeing A Health System s Innovative Approach
The Journey towards Total Wellbeing A Health System s Innovative Approach Company Profile Wellness A state of complete physical, mental and social wellbeing and not merely the absence of disease or infirmity
The Diabetes Link to Heart Disease
The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM
Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?
Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:
SUPPLEMENTARY DATA. Supplementary Methods
Supplementary Methods Chronic kidney disease stage 4 or 5 Current diabetic foot with ulcer, soft tissue infection or necrosis Unstable angina, myocardial infarction, or cerebrovascular accident over the
Congestive Heart Failure: The Complication that Gets No Respect Richard J. Katz, MD Saturday, February 18, :30 a.m. 10:15 a.m.
Congestive Heart Failure: The Complication that Gets No Respect Richard J. Katz, MD Saturday, February 18, 2017 9:30 a.m. 10:15 a.m. The prevalence of the combination of diabetes and both systolic and
Composite Performance Report
Composite Performance Report 10 9 91% 8 7 65% 68% 65% 6 56% 5 4 3 2 44% 37% 48% 31% 19% 29% 1 6% Key: Report Measure Name Cohort Target Cohort Definition Formula 1 Control Blood Pressure All patients who
Weight as a Measure of Health vs. Health at Every Size
Weight as a Measure of Health vs. Health at Every Size Society for Nutrition Education and Behavior 49 th Annual Conference 2016 Glenn Gaesser, PhD Arizona State University (glenn.gaesser@asu.edu) Non-weight-loss-centered
Protocol for IV rtpa Treatment of Acute Ischemic Stroke
Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and
Circulation 1 of 27 Boardworks Ltd 2012
Circulation 1 of 27 Boardworks Ltd 2012 2 of 27 Boardworks Ltd 2012 The exchange of substances 3 of 27 Boardworks Ltd 2012 Single-celled organisms, such as bacteria and amoeba (below), do not need a circulatory
28-Aug-15. RACGP guidelines 2014/15. ADS guidelines Part 1 T2D Guidelines. Part 2 What comes after metformin?
Part 1 T2D Guidelines Oral therapies in T2 diabetes Dr Gary Kilov T2D Guidelines - What s New? What comes after metformin? 1 RACGP guidelines 2014/15 ADA-EASD: Anti-Hyperglycaemic therapy 2015 3 4 Inzucchi
Health Outcomes in the SSHVS Population Study. Loretta R Cain, MPH, PhD The University of Chicago
Health Outcomes in the SSHVS Population Study Loretta R Cain, MPH, PhD The University of Chicago Background Objective measures to assess status of prevalent health conditions are needed to identify: Diagnosed
[E-BOOK] CHRONIC STRESS AND HIGH BLOOD PRESSURE DOCUMENT
![[E-BOOK] CHRONIC STRESS AND HIGH BLOOD PRESSURE DOCUMENT](/thumbs/81/84589008.jpg "[E-BOOK] CHRONIC STRESS AND HIGH BLOOD PRESSURE DOCUMENT")
26 May, 2018 [E-BOOK] CHRONIC STRESS AND HIGH BLOOD PRESSURE DOCUMENT Document Filetype: PDF 233.96 KB 0 [E-BOOK] CHRONIC STRESS AND HIGH BLOOD PRESSURE DOCUMENT High blood pressure (hypertension) doesn't
Appendix. Supplementary figures and tables
This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix. Supplementary figures and tables Figure A1. Flowchart describing patient
Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
Thiazolidinedione-Associated Congestive Heart Failure and Pulmonary Edema
Search the Journal search Advanced Search > Home Current Issue Past Issues Reprints Submissions Subscriptions Permissions About Us MAYO CLIN PROC. 2003;78:1088-1091 2003 MAYO FOUNDATION FOR MEDICAL EDUCATION
Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities
Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities Summary After four years of NHS Health Checks, Barnsley has access to aggregated data on over 47,000 people. This data was analysed
ABSTRACT KEYWORDS: The prevalence of hypertension varies from percentages in all
85 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 6(6): November-December 2017 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND
Hypertension and Heart Disease. Weldon James, MD, Mercy Clinic Family Medicine, Union
Hypertension and Heart Disease Weldon James, MD, Mercy Clinic Family Medicine, Union The Silent Killer High blood pressure, also known as HBP or hypertension, is a widely misunderstood medical condition
ASSeSSing the risk of fatal cardiovascular disease
ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril
Know Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
What is Your Hypertension IQ?
What is Your Hypertension IQ? By: James L. Holly, MD Question: If you are 55 years of age and if you do not have high blood pressure -- hypertension -- what is your risk of developing blood pressure in
Type 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.
Type 2 Diabetes Stopping Smoking Consider referral to smoking cessation BMI > 25 kg m² Set a weight loss target of a 5-10% reduction Consider referring for weight management advice Control BP to
CASE A2 Managing Between-meal Hypoglycemia
Managing Between-meal Hypoglycemia 1 I would like to discuss this case of a patient who, overall, was doing well on her therapy until she made an important lifestyle change to lose weight. This is a common
Nutrition. eart Smart. New Dietary Approaches to Treating Hypertension. By Maureen Elhatton, RD
H eart Smart Nutrition Maureen Elhatton is a registered dietitian involved in the area of cardiac rehabilitation. She specializes in heart health nutrition in Edmonton, Alberta. New Dietary Approaches
Changing Diabetes: The time is now!
Midwest Cardiovascular Research Foundation Welcomes DANITA HARRISON, ARNP Ms. Harrison discloses speaking relationships with Lilly, Novo Nordisk and Pfizer. Changing Diabetes: The time is now! Danita Harrison